Annual Drug Patent Expirations for CONTRAVE
Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are twelve patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CONTRAVE.
This drug has one hundred and seventy-three patent family members in thirty-four countries.
The generic ingredient in CONTRAVE is bupropion hydrochloride; naltrexone hydrochloride. Three suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride; naltrexone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
